These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33661296)

  • 1. Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?
    Eladl E; Chang H
    Blood; 2021 Mar; 137(9):1268. PubMed ID: 33661296
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
    Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H
    Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extramedullary sarcomatoid variant of plasmablastic plasmacytoma.
    Majhi U; Sundersingh S; Murhekar K; Radha K
    J Cancer Res Ther; 2017; 13(6):1078-1079. PubMed ID: 29237987
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma.
    Ahn JS; Okal R; Vos JA; Smolkin M; Kanate AS; Rosado FG
    J Clin Pathol; 2017 Sep; 70(9):775-780. PubMed ID: 28249941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmablastic multiple myeloma with Dutcher bodies.
    Jain D; Singh T
    Indian J Pathol Microbiol; 2008; 51(3):442-3. PubMed ID: 18723987
    [No Abstract]   [Full Text] [Related]  

  • 6. From the archives of MD Anderson Cancer Center: Plasmablastic lymphoma presenting as a kidney mass in an immunocompetent patient: Case report and literature review.
    Gietzen R; Muthukumarana V; Bhargava P; Vozniuk D; Thakral B; Medeiros LJ; Lyapichev KA
    Ann Diagn Pathol; 2023 Dec; 67():152186. PubMed ID: 37541853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmablastic lymphoma of bone marrow: Report of a rare case and immunohistochemistry based approach to the diagnosis.
    Sharma P; Sreedharanunni S; Koshy A; Prakash G; Sachdeva MUS; Malhotra P
    Indian J Pathol Microbiol; 2019; 62(1):107-110. PubMed ID: 30706870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmablastic myeloma transformation of light-chain multiple myeloma.
    Pakasticali N; Hortin GL; Li JY
    J Clin Exp Hematop; 2024 Jun; 64(2):149-151. PubMed ID: 38684404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.
    Mori H; Fukatsu M; Ohkawara H; Oka Y; Kataoka Y; Taito S; Ikezoe T
    Int J Hematol; 2021 Dec; 114(6):639-652. PubMed ID: 34462886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmablastic IgM multiple myeloma with hypocellular bone marrow.
    Arter ZL; Miles D; Mignano S; Cordaro D; Roswarski J
    Ann Hematol; 2020 Apr; 99(4):895-896. PubMed ID: 32055929
    [No Abstract]   [Full Text] [Related]  

  • 11. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
    Paule B; Quillard J; Bennet P; Mariette X; Bisson M
    Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort.
    Møller HE; Preiss BS; Pedersen P; Kristensen IB; Hansen CT; Frederiksen M; Abildgaard N; Møller MB
    APMIS; 2015 Aug; 123(8):652-8. PubMed ID: 26152595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A challenging diagnosis of plasmablastic lymphoma: importance of integrating morpholgy immunohistochemistry and flow cytometry findings (case report).
    Kmira Z; Ahmed G; Wided C; Wided M; Zeineb N; Nihed A; Yosra BY; Regaieg H; Nejia B; Abderrahim K
    Pan Afr Med J; 2023; 45():158. PubMed ID: 37869229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
    Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS
    Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall.
    Pan Z; Chen M; Zhang Q; Wang E; Yin L; Xu Y; Huang Q; Yuan Y; Zhang X; Zheng G; Yuan J
    Mod Pathol; 2018 May; 31(5):718-731. PubMed ID: 29327711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmablastic transformation of multiple myeloma.
    Lee CK; Ma ES; Shek TW; Lam CC; Au WY; Wan TS; Chan LC
    Hum Pathol; 2003 Jul; 34(7):710-4. PubMed ID: 12874768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmablastic lymphoma with aberrant expression of CD3 and CD4.
    Yan J; Sakhdari A
    Int J Lab Hematol; 2022 Aug; 44(4):692-693. PubMed ID: 35060329
    [No Abstract]   [Full Text] [Related]  

  • 18. Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma.
    Marini C; Baldaia H; Trigo F; Castillo JJ
    Am J Hematol; 2016 Aug; 91(8):E324. PubMed ID: 27012155
    [No Abstract]   [Full Text] [Related]  

  • 19. An unusual case of myeloma.
    Tate C; McKinley M; Seymour L
    Pathology; 2018 Aug; 50(5):581-584. PubMed ID: 29921449
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmablastic transformation of a double hit follicular lymphoma: An emerging entity.
    Khodaiji S; Mahajan V; Satyakam KS; Amare PSK
    Indian J Pathol Microbiol; 2024 Apr; 67(2):411-414. PubMed ID: 38391382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.